Portal de investigación
Enfoque integral de la enfermedad micrometastásica hepática en cáncer colorrectal: caracterización multiómica de metástasis, respuesta inmune y abordaje de la enfermedad residual.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer
Prieto-de-la-Lastra C; (...); Tarazona N
Article. 10.1016/j.esmoop.2025.105495. 2025
Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life
Airoldi M; (...); Cervantes A
Review. 10.1016/j.ctrv.2025.103015. 2025
Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis
Camblor DG; (...); Tarazona N
Review. 10.1016/j.ctrv.2025.103066. 2026
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy.
Martínez-Castedo B; (...); Tarazona N
Article. 10.1016/j.annonc.2024.12.006. 2025
Whole-exome ctDNA sequencing reveals intratumoral heterogeneity and drivers of relapse in locally advanced head and neck cancer.
Bruixola G; (...); Tarazona N
Article. 10.1016/j.esmoop.2025.105904. 2025
